ArticleCureus2025
Erythema Multiforme-Like Lesions Revealing Systemic Lupus Erythematosus.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical correlates and predictors of thrombocytopenia in childhood-onset systemic lupus erythematosus: a retrospective cohort study.Pediatric rheumatology online journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rowell syndrome is a rare clinical entity, defined by the association of systemic lupus erythematosus (SLE) and erythema multiforme (EM)-like skin lesions, accompanied by distinctive immunological findings such as a speckled antinuclear antibody (ANA) pattern. It predominantly affects women and requires specific diagnostic criteria. Management depends on the extent and severity of organ involvement. We report the case of a 69-year-old woman who developed severe mucocutaneous erythema multiforme-like lesions and systemic symptoms. Clinical and laboratory findings supported the diagnosis of SLE. Targeted treatment combining corticosteroids and hydroxychloroquine resulted in marked clinical and biological improvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.